Overexpression of PD-L1 has been linked to a poor prognosis and outcome in malignant tumors such as breast cancer, gastrointestinal tract cancer, cholangiocarcinoma, and renal cell carcinoma [11–15]. This evidence concerns the gene CD274 and cancer.